DocGo (NASDAQ:DCGO - Get Free Report) had its target price cut by analysts at Needham & Company LLC from $7.00 to $4.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a "buy" rating on the stock. Needham & Company LLC's price objective indicates a potential upside of 35.14% from the company's current price.
DocGo Price Performance
Shares of DocGo stock traded down $0.03 during trading on Friday, reaching $2.96. 1,875,036 shares of the company traded hands, compared to its average volume of 757,342. The firm has a market capitalization of $302.07 million, a PE ratio of 10.57, a P/E/G ratio of 14.16 and a beta of 1.00. DocGo has a 1-year low of $2.75 and a 1-year high of $5.68. The company has a 50 day moving average price of $4.56 and a 200-day moving average price of $4.02.
Insiders Place Their Bets
In related news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction on Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares of the company's stock, valued at approximately $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.70% of the company's stock.
Hedge Funds Weigh In On DocGo
A number of hedge funds have recently added to or reduced their stakes in DCGO. Centiva Capital LP bought a new position in shares of DocGo in the third quarter valued at approximately $43,000. Summit Investment Advisors Inc. lifted its stake in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after acquiring an additional 2,968 shares in the last quarter. Prudential Financial Inc. bought a new position in DocGo during the 4th quarter valued at $55,000. Intech Investment Management LLC purchased a new position in DocGo during the 3rd quarter worth $62,000. Finally, Royce & Associates LP bought a new stake in shares of DocGo in the 4th quarter worth $64,000. Institutional investors and hedge funds own 56.44% of the company's stock.
About DocGo
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
